Diabetes & Metabolic Diseases Research Program
Announcements
Swine Flu/H1N1 and New Guidelines for Visitors

Christiana Care's Diabetes & Metabolic Diseases Research Program is part of the Christiana Care Research Institute and has participated in more than 100 clinical trials, involving both inpatients and outpatients. The research has covered various aspects and phases of diabetes-related illnesses and treatments, including:

  • Treatment modalities
  • New medications
  • Devices
  • Foot ulcers
  • Neuropathy
  • Gastroparesis
  • Retinopathy

The program staff is made up of:

  • Two nationally certified research coordinators
  • A full-time recruiter
  • Physicians specializing in endocrinology with many years of experience
  • Ph.D.-level research scientist
  • Diabetes educators

If you or someone you know is interested in learning what research studies are going on or are interested in participating in the studies please contact us at:

Christiana Care Diabetes & Metabolic Diseases Research Program
Medical Arts Pavilion 2, Suite 3203
4735 Ogletown-Stanton Rd.
Phone: 302-623-3830
Fax: 302-623-3845
Location & Directions


New Studies Open

 

Study Title

Effect of Renin Inhibition on Cardiovascular Autonomic Nerve Function in
Diabetes
(29011)

Purpose

The purpose of this research study is to test the effectiveness of a
medication to improve nerve function.

Qualifications

  • Individuals 18 years and older with Type 1 or Type 2 diabetes

Benefits

  • Free tests to measure nerve function
  • Payment to you of up to $200

Contact Info

Raelene E. Maser, Ph.D. at 302-623-3834

 
 

Study Title

A Phase 2/3, Randomized, Double-Blind, Multicenter, Multinational, 4-Arm, Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of MGA031, a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adults with Recent-Onset Type 1 Diabetes Mellitus (26227)

Purpose

The purpose of this study is to find out if an experimental drug called MGA031 (also called hOKT3gamma-1 [Ala-Ala]) improves control of sugar in the blood, decreases the need for insulin and is safe for people with Type 1 diabetes mellitus.

Qualifications

  • Have been diagnosed with Type 1 Diabetes is the last 12 weeks
  • Are between 8 and 35 years of age

Benefits

  • Physical examinations
  • Laboratory tests
  • Study medication
  • Reimbursement for time/travel expenses up to $1290.00

Contact Info

Debbie Moore 302-623-3838